KAT2 inhibitors (Orion Pharma/Proteros biostructures/Jubilant Chemsys)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameKAT2 inhibitors (Orion Pharma/Proteros biostructures/Jubilant Chemsys)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Actionkynurenine aminotransferase 2 inhibitors
Targetskynurenine aminotransferase 2
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermanyFinlandIndia
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOrion Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJubilant Chemsys LtdProteros Biostructures GmbHOrion Corp
Active IndicationsN/A
Inactive IndicationsSchizophrenia

Other Information

ATC CodeN/A
Related LinksN/A